Cardiovascular Research laboratory

Our Vision


Translational-oriented research of cardiac pathology

Our Team

  • Prof. Gad Keren, Lab PI, Head of the Cardiovascular Research lab;Cardiology, Sackler School of Medicine.
  • Dr. Michal Entin-Meer, Lab manager

Research

at the peri-infarct zone 3 days post myocardial infarction

The potential involvement of the TRPV2 Ca2+channel in cardiac pathology, oncology and cardiac-oncology. A TRPV2 blocking agent is being developed in collaboration with the BLAVATNIK center for drug discovery.

are highly involved in mediating cardiac pathology and progression to reno-cardiac syndrome following cardiac injury

Highlighted Publications

Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody.

Cohen L, Sagi I, Bigelman E, Solomonov I, Aloshin A, Ben-Shoshan J, Pasmanik-Chor M, Rozenbaum Z, Keren G, Entin-Meer M. PLoS One. 2020 Oct 22;15(10):e0241419.

Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease

lman E, Cohen L, Aharon-Hananel G, Levy R, Rozenbaum Z, Saada A, Keren G, Entin-Meer M. PLoS One. 2018 Jun 11;13(6):e0198196.

 

Increased CD11b+ cells and Interleukin-1 (IL-1) alpha levels during cardiomyopathy induced by chronic adrenergic activation

Ben-Shoshan J, Jubran A, Levy R, Keren G, Entin-Meer M.Isr Med Assoc J. 2017 Sep;19(9):570-575.

TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages

Entin-Meer M, Cohen L, Hertzberg-Bigelman E, Levy R, Ben-Shoshan J, Keren G.PLoS One. 2017 May 8;12(5):e0177132. doi: 10.1371/journal.pone.0177132. eCollection 2017.

}